United States Sleep Apnea Diagnostic Systems Market Outlook to 2025

GlobalData
44 Pages - GLDATA66250
$4,995.00

Summary

GlobalData’s new report, United States Sleep Apnea Diagnostic Systems Market Outlook to 2025, provides key market data on the United States Sleep Apnea Diagnostic Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Fixed Polysomnography Systems and Portable Polysomnography Systems.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Sleep Apnea Diagnostic Systems market segments - Fixed Polysomnography Systems and Portable Polysomnography Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Sleep Apnea Diagnostic Systems market.
- Global corporate-level profiles of key companies operating within the United States Sleep Apnea Diagnostic Systems market.
- Key players covered include Compumedics Ltd, ResMed Inc. Philips Respironics Inc and Others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.



Companies Mentioned
Natus Medical Incorporated
Nihon Kohden Corp
Compumedics Ltd
Cadwell Industries Inc
Advanced Brain Monitoring Inc
ResMed Inc.
Cleveland Medical Devices Inc
Philips Respironics Inc
Vyaire Medical Inc
Drive DeVilbiss Healthcare Ltd

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Sleep Apnea Diagnostic Systems market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Sleep Apnea Diagnostic Systems Market, United States 7
3.1 Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), 2015-2025 7
3.2 Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2015-2025 9
3.3 Sleep Apnea Diagnostic Systems Market, United States, Average Price ($), 2015-2025 11
3.4 Sleep Apnea Diagnostic Systems Market, United States, Distribution Share by Revenue ($m), 2017 12
3.5 Sleep Apnea Diagnostic Systems Market, United States, Company Share by Revenue ($m), 2017 13
4 Overview of Key Companies in United States, Sleep Apnea Diagnostic Systems Market 15
4.1 Natus Medical Incorporated 15
4.1.1 Company Overview 15
4.2 Nihon Kohden Corp 15
4.2.1 Company Overview 15
4.3 Compumedics Ltd 15
4.3.1 Company Overview 15
4.4 Cadwell Industries Inc 15
4.4.1 Company Overview 15
4.5 Advanced Brain Monitoring Inc 16
4.5.1 Company Overview 16
4.6 ResMed Inc. 16
4.6.1 Company Overview 16
4.7 Cleveland Medical Devices Inc 16
4.7.1 Company Overview 16
4.8 Philips Respironics Inc 17
4.8.1 Company Overview 17
4.9 Vyaire Medical Inc 17
4.9.1 Company Overview 17
4.10 Drive DeVilbiss Healthcare Ltd 17
4.10.1 Company Overview 17
5 Sleep Apnea Diagnostic Systems Market Pipeline Products 18
6 Financial Deals Landscape 19
6.1 Venture Financing 19
6.1.1 Invicta Medical Raises USD21 Million in Venture Financing 19
6.1.2 Watermark Medical Raises USD3.25 Million in Venture Financing 20
7 Recent Developments 21
7.1 Corporate Communications 21
7.1.1 Jul 11, 2018: Natus Medical Announces Leadership Changes 21
7.1.2 Apr 17, 2018: Ranir appoints Steve Weinberger as chief financial officer 22
7.1.3 Apr 02, 2018: ResMed Hires Bobby Ghoshal as First Chief Technology Officer 22
7.1.4 Jan 05, 2018: Natus Appoints Leslie McDonnell as Vice President and General Manager of its Newborn Care Business Unit 22
7.1.5 Nov 17, 2017: ResMed Elects Karen Drexler to Its Board of Directors 23
7.2 Financial Announcements 23
7.2.1 Apr 26, 2018: ResMed Announces Results for the Third Quarter of Fiscal Year 2018 23
7.2.2 Apr 25, 2018: Natus Medical Announces First Quarter Financial Results 25
7.2.3 Apr 23, 2018: Philips First Quarter Results 2018 25
7.2.4 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 27
7.2.5 Feb 07, 2018: Natus Medical Announces Fourth Quarter and Full Year 2017 Financial Results 28
7.2.6 Jan 22, 2018: ResMed Reports Second Quarter of Fiscal Year 2018 Financial Results 29
7.2.7 Jan 08, 2018: Natus Medical Announces 2018 Annual and First Quarter Financial Guidance 30
7.2.8 Oct 26, 2017: ResMed Announces Results for the First Quarter of Fiscal Year 2018 31
7.2.9 Oct 25, 2017: Natus Medical Announces Third Quarter 2017 Financial Results 32
7.3 Legal And Regulatory 34
7.3.1 Oct 06, 2017: ResMed's European Patents Infringed by Fisher & Paykel in Germany 34
7.4 Other Significant Developments 34
7.4.1 Nov 02, 2017: Philips provides update on the company strategy and performance at Capital Markets Day in New York 34
7.5 Product News 35
7.5.1 May 21, 2018: Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate 35
7.5.2 Nov 13, 2017: Philips innovations at MEDICA 2017 connect people, technology and data across the health continuum 35
7.5.3 Oct 13, 2017: AASM releases position statement on home sleep apnea testing 36
8 Appendix 38
8.1 Research Methodology 39
8.1.1 Coverage 39
8.1.2 Secondary Research 39
8.1.3 Primary Research 40
8.1.4 Market Modeling and Forecasting 41
8.1.5 Company Share Analysis 42
8.1.6 Distribution Share Analysis 43
8.1.7 Benchmarking 43
8.2 GlobalData Consulting 43
8.3 Contact Us 44
8.4 Disclaimer 44

1.1 List of Tables
Table 1: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 8
Table 2: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 8
Table 3: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2015-2020 10
Table 4: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2021-2025 10
Table 5: Sleep Apnea Diagnostic Systems Market, United States, Average Price ($), 2015-2020 11
Table 6: Sleep Apnea Diagnostic Systems Market, United States, Average Price ($), 2021-2025 11
Table 7: Sleep Apnea Diagnostic Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 12
Table 8: Sleep Apnea Diagnostic Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2017 14
Table 9: Sleep Apnea Diagnostic Systems Market Pipeline Products 18
Table 10: Invicta Medical Raises USD21 Million in Venture Financing 19
Table 11: Watermark Medical Raises USD3.25 Million in Venture Financing 20
Table 12: Total Number of Primary Research Participants, Anesthesia and Respiratory Devices Market, by Country 41

1.2 List of Figures
Figure 1: Sleep Apnea Diagnostic Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 7
Figure 2: Sleep Apnea Diagnostic Systems Market, United States, Volume (Units), 2015-2025 9
Figure 3: Sleep Apnea Diagnostic Systems Market, United States, Company Share (%) 2017 13

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838